Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/1998
11/17/1998US5837842 Vascular anticoagulant proteins DNA which codes them, processer for preparing them and their use
11/17/1998US5837720 N-2-(pyrrolidinyl-1)-1-phenethyl) acetamides as kappa receptor antagonists
11/17/1998US5837717 Hydroxamic acid anesthetic compounds
11/17/1998US5837712 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations
11/17/1998US5837690 Derivatives of triterpenoid acids and uses thereof.
11/17/1998US5837508 Hce3p83 polypeptides and polynucleotides used in the design of protocols for treatment of alzheimer's disease, stroke, cancer, inflammation, arthritis, musculoskeletal disease, heart disease, kidney disease and diagnostic assays for such
11/17/1998US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998US5837490 Therapeutic, diagnostic, research uses
11/17/1998US5837451 Identifying composition which affect kinase activity
11/17/1998US5837252 Extraction with acetone reducing nordihydroguaiaretic quinone present by ascorbic acid
11/17/1998US5837244 Treating a cell proliferative disorder
11/15/1998CA2237450A1 Preparation having increased in vivo tolerability
11/12/1998WO1998050534A1 Protease inhibitors
11/12/1998WO1998050530A2 Enzymatic nucleic acids: synthesis, selection and use
11/12/1998WO1998050434A1 Methods for eosinophil depletion and compositions therefor
11/12/1998WO1998050413A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens
11/12/1998WO1998050412A1 Estrogenic 19-noradnrost-17-one derivatives with an aromatic b-ring
11/12/1998WO1998050372A1 Substituted heterocycles and their use in medicaments
11/12/1998WO1998050367A1 Processes and intermediates for preparing substituted indazole derivatives
11/12/1998WO1998050351A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them
11/12/1998WO1998050342A1 Protease inhibitors
11/12/1998WO1998050073A1 Integrin ligand, human mindin
11/12/1998WO1998050059A1 Method for preventing gastritis using amylin or amylin agonists
11/12/1998WO1998050045A1 Improvements in or relating to long-acting antimicrobials
11/12/1998WO1998050033A1 Cox-2 selective carprofen for treating pain and inflammation in dogs
11/12/1998WO1998049897A1 Beta lactams as antiproliferative agents
11/12/1998CA2289705A1 Beta lactams as antiproliferative agents
11/12/1998CA2289602A1 Protease inhibitors
11/12/1998CA2289548A1 Method for preventing gastritis using amylin or amylin agonists
11/12/1998CA2289094A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them
11/12/1998CA2289010A1 Protease inhibitors
11/12/1998CA2289008A1 Estrenes
11/12/1998CA2288999A1 B-ring estratrienes
11/12/1998CA2288759A1 Cox-2 selective carprofen for treating pain and inflammation in dogs
11/12/1998CA2288640A1 Enzymatic nucleic acids: synthesis, selection and use
11/12/1998CA2288017A1 Methods for eosinophil depletion and compositions therefor
11/11/1998EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998EP0877030A2 EPO primary response gene 1,(EPRG1)
11/11/1998EP0877019A1 Substituted diaminocarboxylic acid
11/11/1998EP0877018A1 Sulfonylaminocarboxylic acids
11/11/1998EP0876817A1 Remedy for keratoconjunctival diseases
11/11/1998EP0876813A1 Composition containing a microorganism culture medium
11/11/1998EP0876487A1 Mammalian cx 3?c chemokine genes
11/11/1998EP0876482A1 Il-13 receptor polypeptide
11/11/1998EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
11/11/1998EP0876393A1 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them
11/11/1998EP0876392A1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
11/11/1998EP0876368A1 Use of mono- or diketone tetracyclic derivatives, resulting novel compounds and therapeutical use thereof
11/11/1998EP0876364A2 Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
11/11/1998EP0876149A1 Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
11/11/1998EP0876143A2 TUMOR NECROSIS FACTOR ALPHA (TNF-$g(a)) INHIBITING PHARMACEUTICALS
11/11/1998EP0876141A2 Preparations of non-steroidal analgesics
11/11/1998EP0720609B1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
11/11/1998CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation
11/11/1998CN1198669A Use of aminoadamantane compound as immunoregulators
11/11/1998CN1198667A Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis
11/11/1998CN1198331A Medicine for curing trigeminal neuralgia
11/11/1998CN1040646C Enatiomeric hydroxylated xanthine compound
11/10/1998US5834587 G-protein coupled receptor, HLTEX 11
11/10/1998US5834512 Administering 6,9-octadecadienoic acid, 8,11-eicosadienoic acid and/or 5,8,11-eicosatrienoic acid
11/10/1998US5834508 Ketone derivatives
11/10/1998US5834504 Modulating, inhibiting abnormal cell proliferation; enzyme inhibition
11/10/1998US5834489 Continuous epidural infusion, minimal motor blockade, anesthetics
11/10/1998US5834487 Inhibition of 26S and 20S proteasome by indanones
11/10/1998US5834478 Morphinan hydroxamic acid compounds
11/10/1998US5834419 Chemokine binding protein and methods of use therefor
11/10/1998US5834290 Skin disorders such as acne, xeroderma, hyperkeratotic conditions, callosities and keratosis pilaris; ichthyoses, psoriasis and eczemas; autoimmune pemphigus, acatholytic diseases, familiar pemphigus and darier's disease
11/10/1998US5834188 For inducing human osteogenic protein 1
11/10/1998US5833996 Treatment of psoriasis using dead cells of Mycobacterium vaccae
11/10/1998US5833990 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides
11/10/1998US5833989 Complement receptor type 1 protein was encoded by plasmides having no more three inserted short consensus repeats nucleotide; use in inflammatory, brain, nevous system and immune disorders
11/10/1998US5833987 Treatment of T cell mediated autoimmune disorders
11/10/1998US5833984 Composition and method for preventing and treating inflammation with Immunoglobulin A
11/10/1998CA2006201C Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors
11/09/1998CA2237052A1 Substituted diaminocarboxylic acids
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/07/1998CA2230986A1 Epo primary response gene 1, eprg1
11/05/1998WO1998049561A1 Inhibitors of nuclear protein/nuclear receptor interaction
11/05/1998WO1998049309A1 Rat st38.2 chemokine
11/05/1998WO1998049305A1 Chimeric opg polypeptides
11/05/1998WO1998049170A1 Spiro-azacyclic derivatives and their use as therapeutic agents
11/05/1998WO1998049169A1 Phosphodiesterase 4-inhibiting diazepinoindolones
11/05/1998WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998WO1998049152A1 Protease inhibitors
11/05/1998WO1998048802A1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
11/05/1998WO1998048627A1 Teat dipping agent
11/05/1998WO1998037094A3 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998032863A3 Mammalian thioredoxin
11/05/1998CA2539919A1 Compositions of aminosugars or fragments of glycosaminoglycans with s-adenosylmethionine for the treatment or repair of connective tissue in mammals
11/05/1998CA2539696A1 Compositions of aminosugars, glycosaminoglycans and s-adenosylmethionine for the treatment or repair of connective tissue in mammals
11/05/1998CA2288351A1 Chimeric opg polypeptides
11/05/1998CA2287876A1 Rat st38.2 chemokine
11/05/1998CA2287567A1 Protease inhibitors
11/05/1998CA2287436A1 Spiro-azacyclic derivatives and their use as therapeutic agents
11/05/1998CA2278217A1 Phosphodiesterase 4-inhibiting diazepinoindolones
11/05/1998CA2259327A1 Teat dipping agent
11/04/1998EP0875577A2 Novel membrane-type matrix metalloproteinase-5 gene
11/04/1998EP0874861A1 Synthetic multivalent slex containing polylactosamines and methods for use
11/04/1998EP0874851A2 Macrocyclic compounds made from suboxide units
11/04/1998EP0874850A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
1 ... 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 ... 1272